Cogent Biosciences (COGT)
(Delayed Data from NSDQ)
$11.36 USD
-0.69 (-5.73%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $11.45 +0.09 (0.79%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Cogent Biosciences, Inc. has a market cap of $1.37B, which represents its share price of $12.05 multiplied by its outstanding shares number of 113.86M. As a small-cap company, COGT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
COGT 11.36 -0.69(-5.73%)
Will COGT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COGT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COGT
COGT Stock Soars on Phase III Systemic Mastocytosis Study Success
Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade
COGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Cogent Biosciences (COGT) Stock a Solid Choice Right Now?
Is Cogent Biosciences (COGT) Outperforming Other Medical Stocks This Year?
Other News for COGT
Cogent Biosciences reports Q2 results
Cogent Biosciences Inc Reports Q2 2025 Net Loss of $73.5 Million Amid Increased R&D Expenses
Cogent Biosciences Inc (COGT) Reports Positive Clinical Trial Results and Strong Financial ...
COGT: Bezuclastinib Shows Promising Results in Key Clinical Trial
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial ...